Veradermics Just Made Minoxidil Pointless

A pharmaceutical company just published the strongest hair regrowth data the FDA has seen in 30 years — and it's not from a new molecule. It's from an old drug, reformulated. Here's what they actually found, what it means for the men currently on minoxidil, and how far away this thing actually is. In this video I break down the Veradermics Phase 2/3 readout on VDPHL01 — the extended-release oral minoxidil they're pushing toward FDA approval. I'll cover the hair-count numbers, the patient-rated outcomes, the safety profile, the mechanism reason this works for guys who don't respond to topical minoxidil, and what to do right now while you wait years for this to actually hit shelves. 📋 What's covered: What VDPHL01 actually is and why "extended-release" matters The Phase 2/3 hair-count and patient-rated results The SULT1A1 mechanism — why oral works for topical non-responders The realistic FDA approval timeline A proven protocol you can run right now instead of waiting 🔗 The free protocol I run myself — all the science that's confirmed and available today, not years away: https://philippeb.pro/protocol/ ⏱ CHAPTERS 0:00 The news 0:53 What Phase 2/3 actually showed 2:30 Why oral works when topical doesn't 4:15 The safety numbers nobody's talking about 5:30 Who actually responds to this 6:45 The FDA timeline — when does this hit shelves 8:15 What to do while you wait 9:30 The bottom line 💬 Would you switch to VDPHL01 the day it gets approved, or stick with what's working right now? Drop a comment. ⸻ 🧴 INTELLIGENT — 10% off with code: PHILIPPE The shampoo and microneedling tools in my routine. Ketoconazole shampoo → https://intelligenthair.com/?ref=phil... Dermapen microneedling tool → https://intelligenthair.com/?ref=phil... ⸻ 🔴 GROWBAND 2.0 (Hairguard) — $100 off + free shipping, extra 10% with code: blueprint The low-level laser cap I use 3x/week. https://www.hairguard.com/?aff=philip... ⸻ 📚 REFERENCED STUDIES Veradermics Phase 2/3 Study 302 readout — VDPHL01 extended-release oral minoxidil, 519 men Vano-Galvan et al. — largest published oral minoxidil safety cohort (1,400+ patients) MANE study — microneedling protocol for androgenetic alopecia Goren et al. — SULT1A1 sulfotransferase enzyme activity in scalp vs liver Ramos et al. — low-dose oral minoxidil in male pattern hair loss ⸻ 🔔 If this video helped, subscribe — I post one deep-dive like this every month. No fluff, just what's working. ⸻ ⚠️ Disclaimer: This video discusses prescription drugs and investigational pharmaceuticals. I'm not a doctor. Nothing here is medical advice. Oral minoxidil is a prescription medication in most countries. VDPHL01 is investigational and not approved by the FDA at the time of recording. Talk to a qualified provider before starting, stopping, or changing any treatment. #HairLoss #OralMinoxidil #VDPHL01 #Veradermics #Minoxidil #HairLossTreatment #HairRegrowth #MalePatternBaldness #AGA #AndrogeneticAlopecia #HairLossNews #HairLoss2026 #FDAApproval #ClinicalTrial #PhaseThree